- STALIF C™ is intended to be used as an IBF cage without supplementary fixation.
- It is inserted between the vertebral bodies into the disc space from levels C2 to T1 for the treatment of cervical degenerative disc disease (defined as neck pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies).
- STALIF C™ is cleared in the US for single level use only.
- STALIF C™ is cleared in the US for use with autograft only.
- STALIF C™ can be used with autograft, allograft, DBM (Demineralised Bone Matrix) or synthetic bone to facilitate fusion OUTSIDE of the US.
- The cervical cage is to be used in a skeletally mature patient who has had six weeks of non-operative treatment prior to implantation of the cage.